PULMONARY SAFETY FOLLOWING DISCONTINUATION AND READMINISTRATION OF INHALED HUMAN INSULIN (EXUBER®) IN ADULT,PATIENTS WITH TYPE 2 DIABETES.
- Published in:
- Journal of Clinical Pharmacology, 2007, v. 47, n. 9, p. 1211
- Publication type:
- Article
Works matching IS 00912700 AND DT 2007 AND VI 47 AND IP 9
Results: 126
1
2
Safety, Tolerability, QTc Evaluation, and Pharmacokinetics of Single and Multiple Doses of Enzastaurin HCl (LY317615), a Protein Kinase C-{beta} Inhibitor, in Healthy Subjects.
- Published in:
- 2007
- By:
- Publication type:
- Journal Article
3
PULMONARY SAFETY FOLLOWING DISCONTINUATION AND READMINISTRATION OF INHALED HUMAN INSULIN (EXUBERA®) IN ADULT PATIENTS WITH TYPE 1 DIABETES.
- Published in:
- 2007
- Publication type:
- Abstract
4
COLD SWIM STRESS INDUCES ANALGESIA BY ACTIVATING ENDOGENOUS CANNABINOID SYSTEM FOLLOWED THROUGH DESCENDING SEROTONERGIC PATHWAYS VIA DORSOLATERAL FUNICULUS.
- Published in:
- 2007
- Publication type:
- Abstract
5
A POPULATION PHARMACOKINETIC MODEL FOR VINCRISTINE IN CHILDREN WITH CANCER.
- Published in:
- 2007
- Publication type:
- Abstract
6
Targeting MDR+ Tumorigenic Progenitors.
- Published in:
- 2007
- Publication type:
- Abstract
7
EVALUATION OF SINGLE ORAL DOSES OF NKTR-118 (PEG-NALOXOL) AS A PERIPHERAL OPIOID ANTAGONIST (POA): A DOUBLE-BLIND PLACEBO-CONTROLLED STUDY IN HEALTHY MALE SUBJECTS.
- Published in:
- 2007
- Publication type:
- Abstract
8
Bioequivalence of Vlldagliptin/Metformln Combination Tablets and Co-administratIon of Vildagliptin and Metformin as Free Combination in Healthy Subjects.
- Published in:
- 2007
- Publication type:
- Abstract
9
Effect of Food on the Pharmacokinetics of Vildagllptln and Metformin In the Fixed Combination Tablets in Healthy Subjects.
- Published in:
- 2007
- Publication type:
- Abstract
10
QUINIDINE-INDUCED QT PROLONGATION IN GUINEA PIG IS AUTOMATICALLY ANALYZED BY MICRO-MAGNETOCARDIOGRAPHY SYSTEM WITH SUPERCONDUCTING QUANTUM INTERFERENCE DEVICE: COMPARISON WITH ECG.
- Published in:
- 2007
- Publication type:
- Abstract
11
APOLIPOPROTEIN E GENOTYPE AND STABLE WARFARIN DOSE REQUIREMENTS.
- Published in:
- 2007
- Publication type:
- Abstract
12
MODELING AND SIMULATION APPROACH TO ADVANCE MOLECULARLY TARGETED PRO-APOPTOTIC AGENTS FOR INFANT LEUKEMIAS.
- Published in:
- 2007
- Publication type:
- Abstract
13
THE EFFECTS OF RENAL FUNCTION AND WEIGHT ON THE PHARMACOKINETICS OF NADROPARIN CALCIUM. II: EVALUATION OF DOSE ADJUSTMENTS IN PATIENTS WITH RENAL IMPAIRMENT (RI).
- Published in:
- 2007
- Publication type:
- Abstract
14
THE EFFECTS OF RENAL FUNCTION AND WEIGHT ON THE PHARMACOKINETICS OF NADROPARIN CALCIUM. I: MODEL DEVELOPMENT.
- Published in:
- 2007
- Publication type:
- Abstract
15
IN-VITRO, IN VIVO, TRANSDERMAL PERMEATION OF CARVEDILOL FROM CHITOSAN BASED MATRIX — TYPE TRANSDERMAL PATCHES.
- Published in:
- Journal of Clinical Pharmacology, 2007, v. 47, n. 9, p. 1208
- Publication type:
- Article
16
LIPOSOMAL AMPHOTERICIN B (FUNGISOME) ™ FOR THE TREATMENT OF SYSTEMIC FUNGAL INFECTIONS (CRYPTOCOCCAL MENINGITIS) IN INDIA — MULTICENTRIC. RANDOMIZED CONTROLLED CLINICAL TRIAL IN HIV/AIDS PATIENTS — INTERIM ANALYSIS OF A PROSPECTIVE STUDY
- Published in:
- 2007
- Publication type:
- Abstract
17
SINGLE-DOSE PHARMACOKINETICS OF ALOGLIPTIN BENZOATE (SYR-322), A HIGHLY SELECTIVE DEPEPTIDYL PEPTIDASE-4 INHIBITOR, IN SUBJECTS WITH MODERATE HEPATIC IMPAIRMENT.
- Published in:
- 2007
- Publication type:
- Abstract
18
ASSESSMENT OF DRUG INTERACTION BETWEEN ALOGLIPTIN BENZOATE (SYR-322), A HIGHLY SELECTIVE DIPEPTIDYL PEPTIDASE-4 INHIBITOR, AND WARFARIN AT STEADY STATE.
- Published in:
- 2007
- Publication type:
- Abstract
19
EFFECT OF FLUCONAZOLE, KETOCONAZOLE, AND GEMFIBROZIL ON THE PHARMACOKINETICS OF ALOGLIPTIN BENZOATE (SYR-322) EN HEALTHY SUBJECTS.
- Published in:
- 2007
- Publication type:
- Abstract
20
Comparison of Genomic Based Dosing Models for Warfarin Initiation.
- Published in:
- 2007
- Publication type:
- Abstract
21
OPEN-LABEL ASSESSMENT OF THE PHARMACOKINETICS OF RAMELTEON 8 MG AND ZOLPIDEM 10MG COADMINISTRATION IN HEALTHY ADULTS.
- Published in:
- 2007
- Publication type:
- Abstract
22
PARAOXON AND ATROPIN DO NOT INCREASE PRALIDOXIME (PRX) PASSAGE THROUGH THE BLOOD BRAIN BARRIER (BBB).
- Published in:
- 2007
- Publication type:
- Abstract
23
EVALUATION OF VANCOMYCIN DOSING REGIMENS IN PRETERM AND TERM NEONATES USING MONTE-CARLO SIMULATIONS.
- Published in:
- 2007
- Publication type:
- Abstract
24
PREDICTIVE POPULATION PHARMACOKINETIC SIMULATIONS TO ASSESS THE BIOEQUIVALENCE OF INHALED CORTICOSTEROIDS.
- Published in:
- 2007
- Publication type:
- Abstract
25
PHARMACOKINETICS AND PHARMACODYNAMICS OF INTRAVENOUS NICARDIPINE IN ANESTHETIZED CARDIAC SURGICAL PATIENTS.
- Published in:
- 2007
- Publication type:
- Abstract
26
THE EFFECT OF CHRONIC RITONAVIR ADMINSTRATION AND COINFECTION WITH CHRONIC VIRAL HEPATITIS ON CYTOCHROME P450 3A ACTIVITY IN HIV+ SUBJECTS.
- Published in:
- 2007
- Publication type:
- Abstract
27
Effect of different dosing report methods on pharmacokinetics or escitalopram.
- Published in:
- 2007
- Publication type:
- Abstract
28
POPULATION PHARMACOKINETICS OF LITHIUM IN EGYPTIAN PATIENTS WITH BIPOLAR AFFECTIVE DISORDER.
- Published in:
- 2007
- Publication type:
- Abstract
29
PHARMACOKINETICS OF RIMONABANT IN JAPANESE AND CAUCASIAN SUBJECTS.
- Published in:
- 2007
- Publication type:
- Abstract
30
PK/PD RELATIONSHIPS IN A SEQUENTIAL, ESCALATING, SINGLE-DOSE STUDY OF PRTX-100, A HIGHLY PURIFIED STAPHYLOCOCCAL PROTEIN A.
- Published in:
- 2007
- Publication type:
- Abstract
31
MILNACIPRAN DOES NOT AFFECT CARDIAC REPOLARIZATION.
- Published in:
- 2007
- Publication type:
- Abstract
32
PHARMACOKINETICS AND PHARMACODYNAMICS OF AZD6140, THE FIRST REVERSIBLE ORAL P2Y<sub>12</sub> RECEPTOR ANTAGONIST, ADMINISTERED WITH ASPIRIN.
- Published in:
- 2007
- Publication type:
- Abstract
33
DIFFERENT FORMULATIONS OF IBUPROFEN LIQUID CAPSULES HAVE DIFFERENT ABSORPTION PROFILES D.
- Published in:
- 2007
- Publication type:
- Abstract
34
PHARMACOKINETIC/PHARMACODYNAMIC (PK/PD) MODELING AND SIMULATION OF CNTO 1275 IN SUBJECTS WITH MODERATE TO SEVERE PSORIASIS VULGARIS.
- Published in:
- 2007
- Publication type:
- Abstract
35
EFFECT OF KETOCONAZOLE ON THE PHARMACOKINETICS OF SAXGALIPTIN IN HEALTHY SUBJECTS.
- Published in:
- 2007
- Publication type:
- Abstract
36
PHARMACOKINETICS OF BELATACEPT IN RENAL TRANSPLANT PATIENTS.
- Published in:
- 2007
- Publication type:
- Abstract
37
SAS-based Discrete Event Simulation (DES) Solution to Evaluate Pediatric Oncology Phase I Trial Designs. Bhuvana Jayaraman.
- Published in:
- 2007
- Publication type:
- Abstract
38
CHARACTERIZATION OF ORENCIA EXPOSURE-EFFICACY RESPONSE IN SUPPORT OF DOSE FOR RHEUMATOID ARTHRITIS.
- Published in:
- 2007
- Publication type:
- Abstract
39
PHARMACOKINETICS AND PHARMACODYNAMICS OF THE ENDOTHELIN-I RECEPTOR ANTAGONIST ACT-064992 IN HEALTHY HUMAN SUBJECTS.
- Published in:
- 2007
- Publication type:
- Abstract
40
THE EFFECT OF VALPROIC ACID ON ACYCLOVIR AFTER INTRAVENOUS AND ORAL ADMINISTRATION IN RABBITS.
- Published in:
- 2007
- Publication type:
- Abstract
41
CHARACTERIZATION OF VASCULAR REACTIVITY AFTER PIOGLITAZONE AND CANDESARTAN TREATMENT IN HEALTHY SUBJECTS.
- Published in:
- 2007
- Publication type:
- Abstract
42
INFLUENCE OF GENDER ON THE ORAL PHARMACOKINETICS OF FLUCONAZOLE.
- Published in:
- 2007
- Publication type:
- Abstract
43
PHARMACOKINETICS AND ANALGESIC EFFECT OF SINGLE DOSE DICLOFENAC AND DICLOFENAC-B VITAMINS IN PATIENTS WITH MODERATE TO SEVERE PAIN.
- Published in:
- 2007
- Publication type:
- Abstract
44
INTERPERSONAL VALUES OF PARTICIPANTS IN PHASE I STUDIES DIFFER FROM NORMAL POPULATION.
- Published in:
- 2007
- Publication type:
- Abstract
45
FEMALES, ANXIOUS SUBJECTS AND SUBJECTS LOW IN PERCEIVED SELF-EFFICACY TEND TO REPORT MORE ADVERSE EVENTS IN PHASE I STUDIES.
- Published in:
- 2007
- Publication type:
- Abstract
46
RISK PERCEPTION AND DECISION TO VOLUNTEER FOR PHASE I STUDIES AMONG NORMAL POPULATION.
- Published in:
- 2007
- Publication type:
- Abstract
47
PERSONALITY OF PARTICIPANTS IN PHASE I STUDIES DIFFERS FROM NORMAL POPULATION.
- Published in:
- 2007
- Publication type:
- Abstract
48
INFLUENCE OF PERSONALITY TRAITS ON THE PROBABILITY OF REPORTING ADVERSE EVENTS IN PHASE I STUDIES IN HEALTHY SUBJECTS.
- Published in:
- 2007
- Publication type:
- Abstract
49
MODEL BASED DEVELOPMENT OF A DIRECT FACTOR Xa INHIBITOR.
- Published in:
- 2007
- Publication type:
- Abstract
50
LACK OF EFFECT OF MILD OR MODERATE HEPATIC IMPAIRMENT ON THE PHARMACOKINETICS OF RIMONABANT.
- Published in:
- 2007
- Publication type:
- Abstract